Mainz Biomed Shares Down 5.7 percent Heres What Happened

MYNZ Stock  USD 6.97  0.18  2.65%   
Slightly above 55% of Mainz Biomed's investors are presently thinking to get in. The analysis of overall sentiment of trading Mainz Biomed BV stock suggests that some investors are interested at this time. Mainz Biomed's investing sentiment can be driven by a variety of factors including economic data, Mainz Biomed's earnings reports, geopolitical events, and overall market trends.
  
Mainz Biomed fell 5.7 percent during trading on Monday . The stock traded as low as 0.21 and last traded at 0.23. 3,189,528 shares traded hands during trading, an increase of 158 percent from the average session volume of 1,236,763 shares. The stock had previously closed at 0.24. Mainz Biomed Stock Performance

Read at thelincolnianonline.com
news
  

Mainz Biomed Fundamental Analysis

We analyze Mainz Biomed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mainz Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mainz Biomed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Mainz Biomed is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Mainz Biomed BV Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mainz Biomed stock to make a market-neutral strategy. Peer analysis of Mainz Biomed could also be used in its relative valuation, which is a method of valuing Mainz Biomed by comparing valuation metrics with similar companies.

Peers

Mainz Biomed Related Equities

NDRAENDRA Life   7.09   
0%
100.0%
STIMNeuronetics   6.72   
0%
94.0%
APDNApplied DNA   6.25   
0%
88.0%
LABStandard Biotools   3.41   
0%
48.0%
PREPrenetics Global   3.20   
0%
45.0%
BDSXBiodesix   3.05   
0%
43.0%
BNRBurning Rock   3.02   
0%
42.0%
DRIODarioHealth Corp   2.67   
0%
37.0%
FONRFonar   0.95   
0%
13.0%
SERASera Prognostics   0.68   
0%
9.0%
MDXHMDxHealth   0.50   
0%
7.0%
STRRPStar Equity   0.55   
7.0%
0%
NOTVInotiv   5.47   
77.0%
0%

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.